An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection

Oral vaccination is the most desirable immunization method by which to prevent fish disease occurring at the early larval stage. We developed an Escherichia coli-based oral nervous necrosis virus (NNV) subunit vaccine and demonstrated its effectiveness in orange spotted grouper ( Epinephelus coioide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Aquaculture 2011-11, Vol.321 (1), p.26-33
Hauptverfasser: Chen, Yi-Min, Shih, Ching-Hung, Liu, Hsiao-Chien, Wu, Cheng-Lung, Lin, Chin-Chiu, Wang, Han-Ching, Chen, Tzong-Yueh, Yang, Huey-Lang, Lin, John Han-You
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 33
container_issue 1
container_start_page 26
container_title Aquaculture
container_volume 321
creator Chen, Yi-Min
Shih, Ching-Hung
Liu, Hsiao-Chien
Wu, Cheng-Lung
Lin, Chin-Chiu
Wang, Han-Ching
Chen, Tzong-Yueh
Yang, Huey-Lang
Lin, John Han-You
description Oral vaccination is the most desirable immunization method by which to prevent fish disease occurring at the early larval stage. We developed an Escherichia coli-based oral nervous necrosis virus (NNV) subunit vaccine and demonstrated its effectiveness in orange spotted grouper ( Epinephelus coioides) fry. However, the incubation period was determined to be over 2 weeks. To enhance the efficacy and shorten the incubation period, a safe and digestible biological adjuvant should be found. Vibrio anguillarum, a common marine bacterium with immune-stimulatory capability was selected as an expression host. An expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter was constructed to express recombinant NNV coat protein as an antigen. The recombinant V. anguillarum was inactivated and encapsulated in Artemia nauplii to formulate a V. anguillarum-based oral vaccine. Compared to the E. coli-based oral vaccine, this novel oral vaccine not only elicited a higher expression of Mx (encoding for an anti-viral protein) in the brain and viscera but also a higher specific antibody titer against NNV in the first week after inoculation. Meanwhile, a higher survival rate compared to an equal dosage of an E. coli-based oral vaccine was also noticed in two individual challenge trials, indicating that an antigen expressed in an V. anguillarum-based oral vaccine could enhance efficacy in a shorter incubation period and could reduce the risk of NNV infection. ► We development an oral nervous necrosis virus vaccine using V. anguillarum as an expression host. ► The expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter. ► This novel oral vaccine elicited a higher expression of Mx in the brain and viscera. ► It also a higher specific antibody titer against NNV in the first week after inoculation. ► The vaccine would shorter incubation period and reduce the risk of NNV infection.
doi_str_mv 10.1016/j.aquaculture.2011.08.035
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902379408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0044848611006831</els_id><sourcerecordid>2481996981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-c2bf4fbe2e4a9ae2a0ebb82c21b392bf1dc1f7fd24be9a5b09f9c89eb18854533</originalsourceid><addsrcrecordid>eNqNkV-L1TAQxYsoeF39DEZBfGqdpGmbPC6X9Q8s-KDra5im02suvcndpC3utzflLiI--TQM88uZkzlF8YZDxYG3H44V3i9ol2leIlUCOK9AVVA3T4odV11dNq0QT4sdgJSlkqp9XrxI6QgAbdvwXRGuPQsRJ-YprmFJudoYkktsdTG3K1rrPLElOX9gP1wfXWDoD4ubJozLiWHKLaNf50gpueDZz5Bmdo5hdQMlRhinh62dyc55_LJ4NuKU6NVjvSruPt58338ub79--rK_vi2trOVcWtGPcuxJkESNJBCo75Wwgve1zjM-WD524yBkTxqbHvSordLUc6Ua2dT1VfH-optX3y-UZnNyyVI27Sl_02gQdaclqEy-_Yc8hiX6bM4o3UHT6rbLkL5A23FSpNGcozthfDAczBaEOZq_gjBbEAaUyUHkt-8eF2CyOI0RvXXpj4CQrehkpzP3-sKNGAweYmbuvmUhCVlfNrC52F8IypdbHUWTrCNvaXAxn9cMwf2Hn98qQ7FT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>897056967</pqid></control><display><type>article</type><title>An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection</title><source>Elsevier ScienceDirect Journals</source><creator>Chen, Yi-Min ; Shih, Ching-Hung ; Liu, Hsiao-Chien ; Wu, Cheng-Lung ; Lin, Chin-Chiu ; Wang, Han-Ching ; Chen, Tzong-Yueh ; Yang, Huey-Lang ; Lin, John Han-You</creator><creatorcontrib>Chen, Yi-Min ; Shih, Ching-Hung ; Liu, Hsiao-Chien ; Wu, Cheng-Lung ; Lin, Chin-Chiu ; Wang, Han-Ching ; Chen, Tzong-Yueh ; Yang, Huey-Lang ; Lin, John Han-You</creatorcontrib><description>Oral vaccination is the most desirable immunization method by which to prevent fish disease occurring at the early larval stage. We developed an Escherichia coli-based oral nervous necrosis virus (NNV) subunit vaccine and demonstrated its effectiveness in orange spotted grouper ( Epinephelus coioides) fry. However, the incubation period was determined to be over 2 weeks. To enhance the efficacy and shorten the incubation period, a safe and digestible biological adjuvant should be found. Vibrio anguillarum, a common marine bacterium with immune-stimulatory capability was selected as an expression host. An expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter was constructed to express recombinant NNV coat protein as an antigen. The recombinant V. anguillarum was inactivated and encapsulated in Artemia nauplii to formulate a V. anguillarum-based oral vaccine. Compared to the E. coli-based oral vaccine, this novel oral vaccine not only elicited a higher expression of Mx (encoding for an anti-viral protein) in the brain and viscera but also a higher specific antibody titer against NNV in the first week after inoculation. Meanwhile, a higher survival rate compared to an equal dosage of an E. coli-based oral vaccine was also noticed in two individual challenge trials, indicating that an antigen expressed in an V. anguillarum-based oral vaccine could enhance efficacy in a shorter incubation period and could reduce the risk of NNV infection. ► We development an oral nervous necrosis virus vaccine using V. anguillarum as an expression host. ► The expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter. ► This novel oral vaccine elicited a higher expression of Mx in the brain and viscera. ► It also a higher specific antibody titer against NNV in the first week after inoculation. ► The vaccine would shorter incubation period and reduce the risk of NNV infection.</description><identifier>ISSN: 0044-8486</identifier><identifier>EISSN: 1873-5622</identifier><identifier>DOI: 10.1016/j.aquaculture.2011.08.035</identifier><identifier>CODEN: AQCLAL</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adjuvant ; adjuvants ; Animal aquaculture ; Animal productions ; antibodies ; antigens ; Aquaculture ; Artemia ; bacteria ; Biological and medical sciences ; brain ; coat proteins ; Epinephelus coioides ; Escherichia ; Fish ; fish diseases ; Fundamental and applied biological sciences. Psychology ; Gene expression ; General aspects ; genes ; grouper ; heat shock proteins ; hosts ; Immunization ; incubation period ; Marine ; Microbiology ; nauplii ; necrosis ; oral vaccination ; Proteins ; Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains ; risk ; Subunit vaccine ; subunit vaccines ; survival rate ; Vibrio anguillarum ; Viral infections ; Virology ; viruses</subject><ispartof>Aquaculture, 2011-11, Vol.321 (1), p.26-33</ispartof><rights>2011 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Nov 16, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-c2bf4fbe2e4a9ae2a0ebb82c21b392bf1dc1f7fd24be9a5b09f9c89eb18854533</citedby><cites>FETCH-LOGICAL-c434t-c2bf4fbe2e4a9ae2a0ebb82c21b392bf1dc1f7fd24be9a5b09f9c89eb18854533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0044848611006831$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65308</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=24627479$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Yi-Min</creatorcontrib><creatorcontrib>Shih, Ching-Hung</creatorcontrib><creatorcontrib>Liu, Hsiao-Chien</creatorcontrib><creatorcontrib>Wu, Cheng-Lung</creatorcontrib><creatorcontrib>Lin, Chin-Chiu</creatorcontrib><creatorcontrib>Wang, Han-Ching</creatorcontrib><creatorcontrib>Chen, Tzong-Yueh</creatorcontrib><creatorcontrib>Yang, Huey-Lang</creatorcontrib><creatorcontrib>Lin, John Han-You</creatorcontrib><title>An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection</title><title>Aquaculture</title><description>Oral vaccination is the most desirable immunization method by which to prevent fish disease occurring at the early larval stage. We developed an Escherichia coli-based oral nervous necrosis virus (NNV) subunit vaccine and demonstrated its effectiveness in orange spotted grouper ( Epinephelus coioides) fry. However, the incubation period was determined to be over 2 weeks. To enhance the efficacy and shorten the incubation period, a safe and digestible biological adjuvant should be found. Vibrio anguillarum, a common marine bacterium with immune-stimulatory capability was selected as an expression host. An expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter was constructed to express recombinant NNV coat protein as an antigen. The recombinant V. anguillarum was inactivated and encapsulated in Artemia nauplii to formulate a V. anguillarum-based oral vaccine. Compared to the E. coli-based oral vaccine, this novel oral vaccine not only elicited a higher expression of Mx (encoding for an anti-viral protein) in the brain and viscera but also a higher specific antibody titer against NNV in the first week after inoculation. Meanwhile, a higher survival rate compared to an equal dosage of an E. coli-based oral vaccine was also noticed in two individual challenge trials, indicating that an antigen expressed in an V. anguillarum-based oral vaccine could enhance efficacy in a shorter incubation period and could reduce the risk of NNV infection. ► We development an oral nervous necrosis virus vaccine using V. anguillarum as an expression host. ► The expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter. ► This novel oral vaccine elicited a higher expression of Mx in the brain and viscera. ► It also a higher specific antibody titer against NNV in the first week after inoculation. ► The vaccine would shorter incubation period and reduce the risk of NNV infection.</description><subject>Adjuvant</subject><subject>adjuvants</subject><subject>Animal aquaculture</subject><subject>Animal productions</subject><subject>antibodies</subject><subject>antigens</subject><subject>Aquaculture</subject><subject>Artemia</subject><subject>bacteria</subject><subject>Biological and medical sciences</subject><subject>brain</subject><subject>coat proteins</subject><subject>Epinephelus coioides</subject><subject>Escherichia</subject><subject>Fish</subject><subject>fish diseases</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene expression</subject><subject>General aspects</subject><subject>genes</subject><subject>grouper</subject><subject>heat shock proteins</subject><subject>hosts</subject><subject>Immunization</subject><subject>incubation period</subject><subject>Marine</subject><subject>Microbiology</subject><subject>nauplii</subject><subject>necrosis</subject><subject>oral vaccination</subject><subject>Proteins</subject><subject>Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains</subject><subject>risk</subject><subject>Subunit vaccine</subject><subject>subunit vaccines</subject><subject>survival rate</subject><subject>Vibrio anguillarum</subject><subject>Viral infections</subject><subject>Virology</subject><subject>viruses</subject><issn>0044-8486</issn><issn>1873-5622</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkV-L1TAQxYsoeF39DEZBfGqdpGmbPC6X9Q8s-KDra5im02suvcndpC3utzflLiI--TQM88uZkzlF8YZDxYG3H44V3i9ol2leIlUCOK9AVVA3T4odV11dNq0QT4sdgJSlkqp9XrxI6QgAbdvwXRGuPQsRJ-YprmFJudoYkktsdTG3K1rrPLElOX9gP1wfXWDoD4ubJozLiWHKLaNf50gpueDZz5Bmdo5hdQMlRhinh62dyc55_LJ4NuKU6NVjvSruPt58338ub79--rK_vi2trOVcWtGPcuxJkESNJBCo75Wwgve1zjM-WD524yBkTxqbHvSordLUc6Ua2dT1VfH-optX3y-UZnNyyVI27Sl_02gQdaclqEy-_Yc8hiX6bM4o3UHT6rbLkL5A23FSpNGcozthfDAczBaEOZq_gjBbEAaUyUHkt-8eF2CyOI0RvXXpj4CQrehkpzP3-sKNGAweYmbuvmUhCVlfNrC52F8IypdbHUWTrCNvaXAxn9cMwf2Hn98qQ7FT</recordid><startdate>20111116</startdate><enddate>20111116</enddate><creator>Chen, Yi-Min</creator><creator>Shih, Ching-Hung</creator><creator>Liu, Hsiao-Chien</creator><creator>Wu, Cheng-Lung</creator><creator>Lin, Chin-Chiu</creator><creator>Wang, Han-Ching</creator><creator>Chen, Tzong-Yueh</creator><creator>Yang, Huey-Lang</creator><creator>Lin, John Han-You</creator><general>Elsevier B.V</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>FBQ</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QR</scope><scope>7ST</scope><scope>7TN</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>F1W</scope><scope>FR3</scope><scope>H94</scope><scope>H95</scope><scope>H98</scope><scope>H99</scope><scope>L.F</scope><scope>L.G</scope><scope>M7N</scope><scope>P64</scope><scope>SOI</scope></search><sort><creationdate>20111116</creationdate><title>An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection</title><author>Chen, Yi-Min ; Shih, Ching-Hung ; Liu, Hsiao-Chien ; Wu, Cheng-Lung ; Lin, Chin-Chiu ; Wang, Han-Ching ; Chen, Tzong-Yueh ; Yang, Huey-Lang ; Lin, John Han-You</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-c2bf4fbe2e4a9ae2a0ebb82c21b392bf1dc1f7fd24be9a5b09f9c89eb18854533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adjuvant</topic><topic>adjuvants</topic><topic>Animal aquaculture</topic><topic>Animal productions</topic><topic>antibodies</topic><topic>antigens</topic><topic>Aquaculture</topic><topic>Artemia</topic><topic>bacteria</topic><topic>Biological and medical sciences</topic><topic>brain</topic><topic>coat proteins</topic><topic>Epinephelus coioides</topic><topic>Escherichia</topic><topic>Fish</topic><topic>fish diseases</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene expression</topic><topic>General aspects</topic><topic>genes</topic><topic>grouper</topic><topic>heat shock proteins</topic><topic>hosts</topic><topic>Immunization</topic><topic>incubation period</topic><topic>Marine</topic><topic>Microbiology</topic><topic>nauplii</topic><topic>necrosis</topic><topic>oral vaccination</topic><topic>Proteins</topic><topic>Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains</topic><topic>risk</topic><topic>Subunit vaccine</topic><topic>subunit vaccines</topic><topic>survival rate</topic><topic>Vibrio anguillarum</topic><topic>Viral infections</topic><topic>Virology</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Yi-Min</creatorcontrib><creatorcontrib>Shih, Ching-Hung</creatorcontrib><creatorcontrib>Liu, Hsiao-Chien</creatorcontrib><creatorcontrib>Wu, Cheng-Lung</creatorcontrib><creatorcontrib>Lin, Chin-Chiu</creatorcontrib><creatorcontrib>Wang, Han-Ching</creatorcontrib><creatorcontrib>Chen, Tzong-Yueh</creatorcontrib><creatorcontrib>Yang, Huey-Lang</creatorcontrib><creatorcontrib>Lin, John Han-You</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Chemoreception Abstracts</collection><collection>Environment Abstracts</collection><collection>Oceanic Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Aquaculture Abstracts</collection><collection>ASFA: Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Marine Biotechnology Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environment Abstracts</collection><jtitle>Aquaculture</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Yi-Min</au><au>Shih, Ching-Hung</au><au>Liu, Hsiao-Chien</au><au>Wu, Cheng-Lung</au><au>Lin, Chin-Chiu</au><au>Wang, Han-Ching</au><au>Chen, Tzong-Yueh</au><au>Yang, Huey-Lang</au><au>Lin, John Han-You</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection</atitle><jtitle>Aquaculture</jtitle><date>2011-11-16</date><risdate>2011</risdate><volume>321</volume><issue>1</issue><spage>26</spage><epage>33</epage><pages>26-33</pages><issn>0044-8486</issn><eissn>1873-5622</eissn><coden>AQCLAL</coden><abstract>Oral vaccination is the most desirable immunization method by which to prevent fish disease occurring at the early larval stage. We developed an Escherichia coli-based oral nervous necrosis virus (NNV) subunit vaccine and demonstrated its effectiveness in orange spotted grouper ( Epinephelus coioides) fry. However, the incubation period was determined to be over 2 weeks. To enhance the efficacy and shorten the incubation period, a safe and digestible biological adjuvant should be found. Vibrio anguillarum, a common marine bacterium with immune-stimulatory capability was selected as an expression host. An expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter was constructed to express recombinant NNV coat protein as an antigen. The recombinant V. anguillarum was inactivated and encapsulated in Artemia nauplii to formulate a V. anguillarum-based oral vaccine. Compared to the E. coli-based oral vaccine, this novel oral vaccine not only elicited a higher expression of Mx (encoding for an anti-viral protein) in the brain and viscera but also a higher specific antibody titer against NNV in the first week after inoculation. Meanwhile, a higher survival rate compared to an equal dosage of an E. coli-based oral vaccine was also noticed in two individual challenge trials, indicating that an antigen expressed in an V. anguillarum-based oral vaccine could enhance efficacy in a shorter incubation period and could reduce the risk of NNV infection. ► We development an oral nervous necrosis virus vaccine using V. anguillarum as an expression host. ► The expression vector containing its heat shock protein 60 gene ( groE) as an inducible promoter. ► This novel oral vaccine elicited a higher expression of Mx in the brain and viscera. ► It also a higher specific antibody titer against NNV in the first week after inoculation. ► The vaccine would shorter incubation period and reduce the risk of NNV infection.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><doi>10.1016/j.aquaculture.2011.08.035</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0044-8486
ispartof Aquaculture, 2011-11, Vol.321 (1), p.26-33
issn 0044-8486
1873-5622
language eng
recordid cdi_proquest_miscellaneous_902379408
source Elsevier ScienceDirect Journals
subjects Adjuvant
adjuvants
Animal aquaculture
Animal productions
antibodies
antigens
Aquaculture
Artemia
bacteria
Biological and medical sciences
brain
coat proteins
Epinephelus coioides
Escherichia
Fish
fish diseases
Fundamental and applied biological sciences. Psychology
Gene expression
General aspects
genes
grouper
heat shock proteins
hosts
Immunization
incubation period
Marine
Microbiology
nauplii
necrosis
oral vaccination
Proteins
Replicative cycle, interference, host-virus relations, pathogenicity, miscellaneous strains
risk
Subunit vaccine
subunit vaccines
survival rate
Vibrio anguillarum
Viral infections
Virology
viruses
title An oral nervous necrosis virus vaccine using Vibrio anguillarum as an expression host provides early protection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A34%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20oral%20nervous%20necrosis%20virus%20vaccine%20using%20Vibrio%20anguillarum%20as%20an%20expression%20host%20provides%20early%20protection&rft.jtitle=Aquaculture&rft.au=Chen,%20Yi-Min&rft.date=2011-11-16&rft.volume=321&rft.issue=1&rft.spage=26&rft.epage=33&rft.pages=26-33&rft.issn=0044-8486&rft.eissn=1873-5622&rft.coden=AQCLAL&rft_id=info:doi/10.1016/j.aquaculture.2011.08.035&rft_dat=%3Cproquest_cross%3E2481996981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=897056967&rft_id=info:pmid/&rft_els_id=S0044848611006831&rfr_iscdi=true